Personalis Inc (PSNL)
5.48
+0.48
(+9.60%)
USD |
NASDAQ |
Nov 05, 14:38
Personalis Total Assets (Quarterly): 185.50M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 185.50M |
March 31, 2024 | 195.28M |
December 31, 2023 | 225.10M |
September 30, 2023 | 226.64M |
June 30, 2023 | 249.04M |
March 31, 2023 | 272.18M |
December 31, 2022 | 292.70M |
September 30, 2022 | 317.86M |
June 30, 2022 | 357.98M |
March 31, 2022 | 380.65M |
December 31, 2021 | 396.53M |
September 30, 2021 | 406.69M |
Date | Value |
---|---|
June 30, 2021 | 383.34M |
March 31, 2021 | 395.51M |
December 31, 2020 | 244.84M |
September 30, 2020 | 248.81M |
June 30, 2020 | 145.52M |
March 31, 2020 | 151.88M |
December 31, 2019 | 157.29M |
September 30, 2019 | 159.69M |
June 30, 2019 | 191.84M |
March 31, 2019 | 57.66M |
December 31, 2018 | 41.67M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
145.52M
Minimum
Jun 2020
406.69M
Maximum
Sep 2021
275.44M
Average
249.04M
Median
Jun 2023
Total Assets (Quarterly) Benchmarks
Repligen Corp | 2.862B |
Myriad Genetics Inc | 1.085B |
Axogen Inc | 188.93M |
CareDx Inc | 466.78M |
Perspective Therapeutics Inc | 385.92M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 73.23M |
Shareholders Equity (Quarterly) | 112.27M |
Debt to Equity Ratio | 0.0203 |
Current Ratio | 3.314 |
Net Debt Paydown Yield | 0.12% |